• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias.

作者信息

Nogami Akihiko, Kurita Takashi, Kusano Kengo, Goya Masahiko, Shoda Morio, Tada Hiroshi, Naito Shigeto, Yamane Teiichi, Kimura Masaomi, Shiga Tsuyoshi, Soejima Kyoko, Noda Takashi, Yamasaki Hiro, Aizawa Yoshifusa, Ohe Tohru, Kimura Takeshi, Kohsaka Shun, Mitamura Hideo

出版信息

J Arrhythm. 2022 Jan 7;38(1):1-30. doi: 10.1002/joa3.12649. eCollection 2022 Feb.

DOI:10.1002/joa3.12649
PMID:35222748
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8851582/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f432/8851582/77ec8d294d2a/JOA3-38-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f432/8851582/0c6b5d95ee11/JOA3-38-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f432/8851582/cb8bccbcaef1/JOA3-38-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f432/8851582/77ec8d294d2a/JOA3-38-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f432/8851582/0c6b5d95ee11/JOA3-38-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f432/8851582/cb8bccbcaef1/JOA3-38-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f432/8851582/77ec8d294d2a/JOA3-38-1-g001.jpg

相似文献

1
JCS/JHRS 2021 guideline focused update on non-pharmacotherapy of cardiac arrhythmias.《日本循环学会/日本心律学会2021年心律失常非药物治疗指南重点更新》
J Arrhythm. 2022 Jan 7;38(1):1-30. doi: 10.1002/joa3.12649. eCollection 2022 Feb.
2
JCS/JHRS 2021 Guideline Focused Update on Non-Pharmacotherapy of Cardiac Arrhythmias.《日本循环学会/日本心律学会2021年心律失常非药物治疗指南重点更新》
Circ J. 2022 Jan 25;86(2):337-363. doi: 10.1253/circj.CJ-21-0162. Epub 2022 Jan 6.
3
JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias.《日本循环学会/日本心律学会2019年心律失常非药物治疗指南》
Circ J. 2021 Jun 25;85(7):1104-1244. doi: 10.1253/circj.CJ-20-0637. Epub 2021 Jun 1.
4
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.《日本循环学会/日本心律学会2020年心律失常药物治疗指南》
Circ J. 2022 Oct 25;86(11):1790-1924. doi: 10.1253/circj.CJ-20-1212. Epub 2022 Mar 11.
5
CORRIGENDUM: JCS/JHRS 2019 Guideline on Non-Pharmacotherapy of Cardiac Arrhythmias.勘误：《日本循环学会/日本心律学会2019年心律失常非药物治疗指南》
Circ J. 2021;85(9):1692-1700. doi: 10.1253/circj.CJ-66-0196.
6
JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias.《日本循环学会/日本心律学会2019年心律失常非药物治疗指南》
J Arrhythm. 2021 Jun 2;37(4):709-870. doi: 10.1002/joa3.12491. eCollection 2021 Aug.
7
JCS/JHRS 2020 Guideline on Pharmacotherapy of Cardiac Arrhythmias.《日本循环学会/日本心律学会2020年心律失常药物治疗指南》
J Arrhythm. 2022 Oct 25;38(6):833-973. doi: 10.1002/joa3.12714. eCollection 2022 Dec.
8
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.《日本循环学会/日本心律学会2022年心律失常诊断与风险评估指南》
Circ J. 2024 Aug 23;88(9):1509-1595. doi: 10.1253/circj.CJ-22-0827. Epub 2023 Sep 11.
9
JCS/JHRS 2022 Guideline on Diagnosis and Risk Assessment of Arrhythmia.《日本循环学会/日本心律学会2022年心律失常诊断与风险评估指南》
J Arrhythm. 2024 Jun 12;40(4):655-752. doi: 10.1002/joa3.13052. eCollection 2024 Aug.
10
JCS/JHRS Guideline: Rivaroxaban Not Recommended for Patients With Nonvalvular Atrial Fibrillation and High Bleeding Risk.日本循环学会/日本心律学会指南：不推荐利伐沙班用于非瓣膜性心房颤动且出血风险高的患者。
Circ J. 2022 Jun 24;86(7):1204. doi: 10.1253/circj.CJ-22-0146. Epub 2022 May 27.

引用本文的文献

1
Impact of NT-proBNP reduction on recurrence after cryoballoon pulmonary vein isolation and left atrial roof ablation in persistent atrial fibrillation.N末端B型利钠肽原降低对持续性心房颤动患者冷冻球囊肺静脉隔离及左心房顶部消融术后复发的影响
Heart Vessels. 2025 Jun 6. doi: 10.1007/s00380-025-02559-x.
2
SHDB-AF: a Japanese Holter ECG database of atrial fibrillation.SHDB-AF：一个日本心房颤动动态心电图数据库。
Sci Data. 2025 Mar 19;12(1):454. doi: 10.1038/s41597-025-04777-4.
3
Assessment of adverse events stratified by timing of leadless pacemaker implantation with cardiac implantable electronic devices extraction due to infection: A systematic review and meta-analysis.

本文引用的文献

1
JCS/JHRS 2019 guideline on non-pharmacotherapy of cardiac arrhythmias.《日本循环学会/日本心律学会2019年心律失常非药物治疗指南》
J Arrhythm. 2021 Jun 2;37(4):709-870. doi: 10.1002/joa3.12491. eCollection 2021 Aug.
2
JCS/JHFS 2021 Statement on Palliative Care in Cardiovascular Diseases.日本循环学会/日本心力衰竭学会2021年心血管疾病姑息治疗声明。
Circ J. 2021 Apr 23;85(5):695-757. doi: 10.1253/circj.CJ-20-1127. Epub 2021 Mar 26.
3
Deactivation of implantable cardioverter defibrillator in Japanese patients with end-stage heart failure.
因感染而进行心脏植入式电子设备拔除时，按无导线起搏器植入时间分层的不良事件评估：一项系统评价和荟萃分析。
J Arrhythm. 2024 Dec 26;41(1):e13208. doi: 10.1002/joa3.13208. eCollection 2025 Feb.
4
Does Sinus Rhythm Restoration in Patients With Atrial Fibrillation Undergoing Pulmonary Vein Isolation Have Acute Hemodynamic Benefits?接受肺静脉隔离术的房颤患者恢复窦性心律是否具有急性血流动力学益处？
Cardiol Res. 2024 Aug;15(4):298-308. doi: 10.14740/cr1692. Epub 2024 Aug 20.
5
Editorial to "Safety and feasibility of atrial fibrillation ablation after left atrial appendage closure: A single-center experience of the left atrial appendage closure-first strategy".《左心耳封堵术后房颤消融的安全性与可行性：左心耳封堵优先策略的单中心经验》编者按
J Arrhythm. 2024 Jun 18;40(4):891-892. doi: 10.1002/joa3.13097. eCollection 2024 Aug.
6
Impact of left ventricular diastolic function and direct oral anticoagulant use for predicting embolic events in patients with heart failure and atrial fibrillation.左心室舒张功能及直接口服抗凝剂的使用对预测心力衰竭合并心房颤动患者栓塞事件的影响。
J Arrhythm. 2024 Mar 26;40(3):489-500. doi: 10.1002/joa3.13031. eCollection 2024 Jun.
7
A randomized controlled trial of the size-adjustable cryoballoon vs conventional cryoballoon for paroxysmal atrial fibrillation: The CONTRAST-CRYO II trial rationale and design.一项关于尺寸可调式冷冻球囊与传统冷冻球囊治疗阵发性心房颤动的随机对照试验：CONTRAST-CRYO II试验的原理与设计。
Heart Rhythm O2. 2024 Apr 12;5(5):301-306. doi: 10.1016/j.hroo.2024.04.006. eCollection 2024 May.
8
Energy landscape analysis and time-series clustering analysis of patient state multistability related to rheumatoid arthritis drug treatment: The KURAMA cohort study.能量景观分析和与类风湿关节炎药物治疗相关的患者状态多稳定性的时间序列聚类分析：KURAMA 队列研究。
PLoS One. 2024 May 6;19(5):e0302308. doi: 10.1371/journal.pone.0302308. eCollection 2024.
9
Urinary isoxanthopterin as a novel predictor following catheter ablation for atrial fibrillation.尿异黄蝶呤作为心房颤动导管消融术后的一种新型预测指标。
J Arrhythm. 2023 Feb 27;39(2):159-165. doi: 10.1002/joa3.12828. eCollection 2023 Apr.
10
The Atrial Natriuretic Peptide-to-brain Natriuretic Peptide Ratio Predicts Left Atrial Reverse Remodeling after Rhythm Control Therapy in Patients with Persistent Atrial Fibrillation.利钠肽原/脑利钠肽比值预测持续性心房颤动患者节律控制治疗后左心房逆向重构。
Intern Med. 2023 Nov 15;62(22):3283-3290. doi: 10.2169/internalmedicine.1478-22. Epub 2023 Feb 22.
日本终末期心力衰竭患者植入式心律转复除颤器的停用
J Arrhythm. 2020 Nov 24;37(1):196-202. doi: 10.1002/joa3.12465. eCollection 2021 Feb.
4
Optimal interruption time of dabigatran oral administration to ablation (O-A time) in patients with atrial fibrillation: Integrated analysis of 2 randomized controlled clinical trials.达比加群酯口服给药中断时间（O-A 时间）对心房颤动患者消融的影响：2 项随机对照临床试验的综合分析。
J Cardiol. 2021 Jun;77(6):652-659. doi: 10.1016/j.jjcc.2020.12.010. Epub 2021 Jan 25.
5
Pros and Cons of Left Bundle Branch Pacing: A Single-Center Experience.左束支起搏的优缺点：单中心经验。
Circ Arrhythm Electrophysiol. 2020 Dec;13(12):e008874. doi: 10.1161/CIRCEP.120.008874. Epub 2020 Nov 16.
6
Cryoablation or Drug Therapy for Initial Treatment of Atrial Fibrillation.冷冻消融或药物治疗用于初始治疗心房颤动。
N Engl J Med. 2021 Jan 28;384(4):305-315. doi: 10.1056/NEJMoa2029980. Epub 2020 Nov 16.
7
Cryoballoon Ablation as Initial Therapy for Atrial Fibrillation.冷冻球囊消融术作为心房颤动的初始治疗。
N Engl J Med. 2021 Jan 28;384(4):316-324. doi: 10.1056/NEJMoa2029554. Epub 2020 Nov 16.
8
Comparison between his-bundle pacing and left bundle branch pacing in patients with atrioventricular block.房室传导阻滞患者希氏束起搏与左束支起搏的比较。
J Interv Card Electrophysiol. 2021 Oct;62(1):63-73. doi: 10.1007/s10840-020-00869-w. Epub 2020 Sep 21.
9
Early Rhythm-Control Therapy in Patients with Atrial Fibrillation.心房颤动患者的早期节律控制治疗。
N Engl J Med. 2020 Oct 1;383(14):1305-1316. doi: 10.1056/NEJMoa2019422. Epub 2020 Aug 29.
10
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会（ESC）与欧洲心胸外科学会（EACTS）合作制定的心房颤动诊断和管理指南：欧洲心脏病学会（ESC）心房颤动诊断和管理特别工作组，由ESC欧洲心律协会（EHRA）特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.